Andrew Sochacki, MD

Andrew Sochacki, MD

Oncology in Nashville, TN


 (615) 936-2000

Hide Show

About Dr. Sochacki


Dr. Andrew Sochacki, MD is an oncologist in Nashville, Tennessee. He is currently licensed to practice medicine in Tennessee.

Qualifications and Experience



Hide Show

Education & Training

Vanderbilt University
Fellowship, Hematology/Oncology, 2017 - 2020

Vanderbilt University
Residency, Internal Medicine, 2014 - 2017

Michigan State University College of Human Medicine
Class of 2014

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Medical Licenses

MI State Medical License
2019 - 2022

TN State Medical License
2016 - 2021

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Awards

Inductee
Alpha Omega Alpha Honor Medical Society

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Publications



PubMed

Mutational landscape of myelodysplastic/myeloproliferative neoplasm - unclassifiable (MDS/MPN-U).
Blood
Bose, P.,Nazha, A.,Komrokji, R. S.,Patel, K. P.,Pierce, S. A.,Al-Ali, N.,Sochacki, A.,Shaver, A.,Ma, W.,Su, X.,Daver, N. G.,DiNardo, C. D.,Garcia-Manero, G.,Loghavi, S.,Bueso-Ramos, C.,Kantarjian, H. M.,Sekeres, M. A.,Savona, M. R.,Maciejewski, J. P.,Verstovsek, S.
9/23/2018

Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.
OncoTargets and therapy
Sochacki, A. L., Fischer, M. A., Savona, M. R.
5/5/2016

The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models.
Diabetes
Opreanu M Tikhonenko M Bozack S Lydic TA Reid GE McSorley KM Sochacki A Perez GI Esselman WJ Kern T Kolesnick R Grant MB Busik JV
2011 Sep
38 citations

See All

Lecture

Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis
Andrew Sochacki
12/7/2019
61st Annual American Society of Hematology Meeting - Orlando, FL

Abstract

Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase Inhibition
61st Annual American Society of Hematology Meeting
Andrew Sochacki
12/9/2019
Orlando, FL

Next generation myelofibrosis risk analysis in the electronic health record.
American Society of Hematology Annual Meeting
Andrew L. Sochacki, Cosmin Adrian Bejan, Shilin Zhao, Travis Spaulding, Thomas Stricker, Yaomin Xu, Michael R. Savona
12/2018
San Diego, California

Identification of myelofibrosis from electronic health records with novel algorithms and JAKextractor.
Proceedings of the Annual Meeting of the American Association for Cancer Research
Cosmin Adrian Bejan, Andrew Sochacki, Shilin Zhao, Yaomin Xu, Michael Savona
4/2018
Chicago, Illinois

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄